Skip to content

Bausch + Lomb BLCO Operating Income

Operating Income at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$31M-117%
Glaukos logo
GlaukosGKOS
-$19.86M+4.0%
AbbVie logo
AbbVieABBV
$3.99B+6.9%
Warby Parker logo
Warby ParkerWRBY
$1.67M-32.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$642.9M+8.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ

Segments

By segment

See full
Vision Care$202M+14.8%
Pharmaceuticals$66M+500%
Surgical$9M+229%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.3B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's operating income?
Bausch + Lomb (BLCO) reported operating income of $33M in Q1 2026.
How has Bausch + Lomb's operating income changed year-over-year?
Bausch + Lomb's operating income increased by 139.8% year-over-year, from -$83M to $33M.
What is the long-term trend for Bausch + Lomb's operating income?
Over 4 years (2021 to 2025), Bausch + Lomb's operating income has grown at a -23.4% compound annual growth rate (CAGR), from $329M to $113M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.